Related Experiment Video
Updated: May 2, 2026

Expression, Purification, and Antimicrobial Activity of S100A12
Published on: May 13, 2017
Role of calprotectin in cardiometabolic diseases
Peter Kruzliak1, Jan Novák2, Miroslav Novák3
1Department of Cardiovascular Diseases, International Clinical Research Center, St. Anne' University Hospital Brno, Brno, Czech Republic; Institute of Normal and Pathological Physiology and Centre of Excellence for Regulatory Role of Nitric Oxide in Civilisation Diseases, Slovak Academy of Sciences, Bratislava, Slovak Republic.
Insights
Calprotectin, a marker of inflammation, shows promise as a prognostic factor for cardiovascular and cardiometabolic diseases. This peptide may help predict the progression of atherosclerosis and related conditions.
Area of Science:
- Biochemistry
- Immunology
- Cardiology
Background:
- Calprotectin is a peptide secreted by neutrophils and monocytes during inflammation.
- It is a known biomarker for inflammatory bowel diseases.
- Cardiovascular and cardiometabolic diseases are linked to low-grade chronic inflammation.
Purpose of the Study:
- To review the role of calprotectin in cardiometabolic risk.
- To explore calprotectin's potential as a prognostic factor for cardiovascular diseases.
- To highlight calprotectin's utility in diagnosing and stratifying risk for cardiometabolic conditions.
Main Methods:
- Literature review of studies on calprotectin and inflammation.
- Analysis of research linking calprotectin to cardiovascular and cardiometabolic diseases.
- Synthesis of evidence regarding calprotectin's diagnostic and prognostic value.
Main Results:
- Calprotectin is involved in inflammatory processes.
- Emerging evidence suggests calprotectin as a prognostic marker for cardiovascular diseases.
- Calprotectin may predict the course of atherosclerosis, coronary artery disease, and acute coronary syndromes.
Conclusions:
- Calprotectin's role extends beyond inflammatory bowel diseases.
- It holds significant potential as a prognostic biomarker for cardiometabolic risk.
- Further research is warranted to fully establish calprotectin's clinical utility in cardiology.
Abstract:
Calprotectin represents an interesting peptide known to be involved in the pathophysiology of various inflammatory processes. Being secreted from activated neutrophils and monocytes under various conditions, it can also be found in the extracellular fluids and serve as a biomarker of ongoing inflammation, which property is currently used in the monitoring of inflammatory bowel diseases. Recent studies, however, suggest that calprotectin could serve as an important prognostic factor for cardiovascular and cardiometabolic diseases, since these are occurring on the basis of low-grade chronic inflammation. We assume that calprotectin may represent a useful marker in predicting the course of atherosclerotic process, coronary artery disease and acute coronary syndromes. Our review is focused on the importance of calprotectin in the diagnosis and prognostic stratification in the field of cardiometabolic risk.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

